PART 1. REFRAMING THE LIFE

Chapter 4. Infection and Inflammation 

The Anthrax Patient

In 2003, while sitting in my office in Manassas, Virginia, I was preparing another lecture for my biodefense students at George Mason University. My thoughts revolved around anthrax—its pathogenesis, safety measures, and clinical manifestations. Suddenly, a memory surfaced—an incident from the mid-1980s, when I was directing the anthrax development facility in Stepnogorsk. An incident I now call a lesson in confidence - or perhaps, in overconfidence.

The Stepnogorsk anthrax production facility in Kazakhstan, where large-scale research on Bacillus anthracis was conducted during the Soviet biological weapons program.

One early morning, I was having breakfast with my children when the phone rang. In those days, a call before seven a.m. never brought good news. It was almost always a problem—and almost always mine.

“Good morning, Kanatjan,” came the tense voice of Dr. Vladimir Bobrov, the chief medical officer of our health unit. He was responsible for vaccinations and emergency response in case of infection.

“Good morning,” I replied.

“You need to come to the site immediately. I’d rather not discuss this on the phone.”

I understood at once: something serious. If Bobrov was calling, it wasn’t about a headache or a fever.

Half an hour later, I was at the facility. Bobrov met me at the elevator with a young woman doctor, a new member of his team. Judging by their faces, they had just been arguing.

The first thing I heard was Bobrov’s sharp question: “Why are you so sure it’s an infection?”

“I’m not one hundred percent sure,” she said calmly. “But if there’s even a minimal risk, we must act.”

I felt a chill. Could it be inhalational anthrax? If so, the chances of survival were slim.

We went to my office. “Explain,” I said to Bobrov.

“Maybe I overreacted,” he replied. “It could be a false alarm.”

I relaxed a bit, but asked the young doctor to describe what she had seen. Inside, I thought she was simply being cautious—young, inexperienced, but diligent. She began to speak confidently, almost by the book:

“Comrade Director, I was in the examination room. The nurse noticed redness on the technician's neck as the technician entered the controlled zone. We decided not to let him in. There’s a suspicion of contact with anthrax spores—possibly an early cutaneous form.”

Technically, she was right. But as someone who knew every clinical detail of anthrax, I nearly smiled. An ulcer beginning with a red spot? Really? Still, I said nothing.

“Where is he now?” “In the waiting room.”

We went there. The technician was calm, apparently pleased at the prospect of a paid day off. On his neck were a few small blister-classic herpes, by the look of them.

“See the vesicles?” I said. “Looks like herpes, not anthrax.”

She nodded but persisted: “We still have to rule out anthrax.”

I was starting to get irritated, but agreed. “Fine. Take a smear.”

The smear was taken and stained. Bobrov and I took turns at the microscope. Cocci—yes. Bacilli—none.

“See?” I said triumphantly. “Only streptococci. No anthrax.”

I patted her shoulder condescendingly. “Don’t worry. You’re young yet. Experience takes time.”

Only later did I remember that I was only thirty-four at the time—perhaps three or four years older than she was. A very “mature professor,” indeed.

She blushed but said nothing. I was ready to close the case when I suddenly recalled the words of my old military field medicine instructor, Colonel Lieberman: “Don’t look for proof of your theory. Look for the truth.”

And the truth was that a smear alone proves nothing. The pathogen might be hiding among normal microflora. I told my deputy, Colonel Gennady Lepyoshkin, to run a full culture analysis.

The Mistake

Later, Gennady came into my office.“Kan, seriously? Why encourage that young doctor’s imagination? It’s not anthrax.”

“I think so too,” I said. “But we’re obliged to check.”

The next day, before visiting the lab, I decided to look in on the patient again.

And then - I froze. Those “herpetic” vesicles had, overnight, turned into the classic ulcerative form. I already knew what I would see in the Petri dishes: colonies of Bacillus anthracis. Textbook-perfect. I made a smear myself, stained it myself, looked through the microscope—and there they were: neat chains of bacilli with oval spores. Just like in the manual.

The diagnosis was obvious. Yes, further testing was needed, but everything was clear.

I went back to my office, shaken. How could I, an anthrax specialist, have forgotten that the disease doesn’t begin with an “ulcer” but with itching and vesicles? How could I have been so sure of being right?

I was angry at myself. But anger helps little. Worse, the patient hadn’t received antibiotics in time—because I had been convinced I couldn’t be mistaken.

I called Bobrov. “Prepare a hospital room immediately.” “For whom?” “For an anthrax patient.”

Silence. “Why didn’t you believe me yesterday?” he muttered. “Vladimir, you didn’t believe either.” “But you’re the expert—you should have known.”

And that’s when I remembered the young woman—the only person in the room who had been right.

Combined Therapy

We began treatment. Bobrov and I discussed the options. There weren’t many: penicillin, tetracycline, and doxycycline.

The next morning, I asked Bobrov, “How’s our patient? ”Frankly, it was a routine question. I expected to hear, “Stable,” or “Improving. ”The answer stunned me. “He got much worse overnight. Fever spiked. Neck swelling increased. He’s struggling to breathe.”

We intensified ventilation, increased tetracycline, and added ciprofoxacin. But the disease progressed alarmingly fast.

By morning, I realized we might lose him. Most likely because it was caused by strain 836, a highly virulent anthrax variant.

The swelling had spread down to his chest. He was suffocating. The fever remained high. His body was failing.

I sent Gennady to see for himself. Two hours later, he returned, changed, pale, as if from surgery. “It’s worse than they said. The swelling’s down to his abdomen. He can barely breathe. And… I think hemolysis and a septic state have begun.”

I went myself—and saw what I had feared. Bluish skin, shallow labored breathing. He lay silently, eyes filled with fear—and an almost childlike trust. He knew he might die, but still hoped we could save him. I knew he had three small children.

In my office, I looked at Gennady. “Do you think there’s any chance of us injecting the anti-anthrax immunoglobulin? ”He sighed. “We should’ve done it yesterday. Now it may be too late.”

“Yesterday he was still joking and eating…”

But we had no choice. I ordered three or four doses of experimental anthrax immunoglobulin, increased antibiotic dosages, and anti-inflammatory infusions. At the time, it felt desperate; today, I would call it scientific.

We stayed in my office, calling the medical unit every half hour. By ten p.m.—first report: temperature down. By midnight—second: he’d eaten some soup and fallen asleep. Ordinary words that meant everything.

When I saw him the next morning at eleven, he was sitting up and smiling. Temperature normal. Swelling gone. Skin pink, not blue. He even asked if he could tell his wife he was fine. He would live.

Understanding Infection and Inflammation

That was my first experience with combined anthrax therapy—antibiotics plus specific immunoglobulin, and anti-inflammatory medication infusion. It worked: faster, steadier, more effectively than antibiotics alone.

But what struck me most was that the infection itself had not yet destroyed him. What nearly killed him was the inflammation—the massive, uncontrollable edema spreading through his neck, chest, and abdomen. His body was drowning in its own fluids, the swelling compressing his lungs and heart, preventing him from breathing. It was then, watching him suffocate not from bacteria but from his own immune response, that I truly understood what inflammation is. It is not a symptom; it is a force. It can preserve life—or take it. That was my first real encounter with inflammation as a deadly biological phenomenon—a process that, once unleashed, can become more lethal than the infection that caused it.

But what mattered more to me was the realization that even an expert can be wrong—and that a young doctor, unafraid to ask an inconvenient question, can save a life.

This case taught me more than medical tactics. It reminded me that theory never saves anyone—only the willingness to see beyond one’s own certainty does.

Later, I pondered the mechanism. I believe the anthrax pathogen has many more antigens capable of triggering strong inflammation and hemolysis, and that a polyvalent specific immunoglobulin, combined with antibiotics and anti-inflammatory medications, that blocks Bacillus anthracis cell determinants, likely neutralizes them—stopping the destruction and saving the patient.